We have all watched the tense ER scenes play out in our favorite medical dramas. The team of nurses and doctors rush to intubate a patient with respiratory failure. The tension builds as the doctor tries to carefully navigate the tube down the trachea as time runs out for the patient. If it goes as planned, the scene ends with the steady hiss of a ventilator. No hiss-well, you know the ending.

Doctors and nurses often find themselves tangled in paperwork and red tape, which can get in the way of the compassionate care they want to provide. Patients, too, face their own hurdles, from navigating insurance to dealing with social and economic challenges that affect their health. Recognizing these struggles, Katrina Jamison founded Equivio Health Partners with a clear mission: to simplify healthcare and empower both providers and patients to focus on what really matters—getting better and staying healthy.

Finding healthier and eco-friendly products can be a real challenge for many people. Costs are often higher, choices can be limited, and it's easy to feel overwhelmed about where to shop. That's where Makeena is making a difference.

Mental health support is more important now than ever. However, many individuals face barriers to accessing timely and effective therapy. Traditional systems often involve long waiting periods and difficulties in connecting with the right therapist. Start Talking is here to change that narrative, offering a comprehensive platform that addresses these challenges head-on.

A new study reveals that semaglutide, a key ingredient in Ozempic and Wegovy, reduces the risk of dying from Covid-19 by 33%, [otentially boosting its market value.

Peloton will charge a $95 activation fee for new subscribers who buy used equipment, aiming to cover setup costs and boost revenue, as the company sees a 16% increase in new customers from the secondary market.

Johnson & Johnson is nearly announcing a $6.48 billion settlement to resolve talc-related cancer claims, with at least 75% of claimants supporting the deal. He plans to use a bankruptcy strategy to settle all current and future claims.

Biden administration announced that new negotiated prices for ten costly prescription drugs will save Medicare $6 billion and beneficiaries $1.5 billion starting in January 2026.

The iMetabolic Biopharma Corporation (iMBP) is tackling the challenge head-on with its proprietary iPlatformTM, which is a cutting-edge fusion of biotechnology and artificial intelligence (AI). "Our solution is techbio (technology-enhanced biopharma), which has led to the establishment of a proprietary multi-drug candidate pipeline and AI drug discovery technology," explains Founder and CEO Dr. Urban A. Kiernan.

Foreign acquisitions of Chinese pharmaceutical companies have raised national security concerns, as industry experts worry about the potential impact on China's healthcare sector and access to essential medicines.